At the request of Croatia, the European Medicines Agency EMA has initiated a review procedure on 1 December 2016. It concerns injectable medicinal products with the active substance methylprednisolone that additionally contain lactose from cows' milk (and thus traces of milk protein).

For details on the procedure please click on the following link to the homepage of the European Medicines Agency (EMA):

Medicinal products containing lactose of bovine origin for IV/IM use in acute allergic reactions